Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.
People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.
Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.
The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable.
The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.
The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.
A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.
There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.